Alfonso Quintás-Cardama
Chief Tech/Sci/R&D Officer bij FOGHORN THERAPEUTICS INC.
Vermogen: - $ op 29-02-2024
Profiel
Currently, Alfonso Quintás-Cardama occupies the position of Chief Medical Officer for Foghorn Therapeutics, Inc.
In his past career he was Head-Cell & Gene Therapies Unit at GSK Plc, Chief Medical Officer for TCR2 Therapeutics, Inc. and Assistant Professor at The University of Texas M.D.
Anderson Cancer Center.
He received a doctorate from the University of Santiago de Compostela.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
24-01-2024 | 0 ( -.--% ) | - $ | 29-02-2024 |
Actieve functies van Alfonso Quintás-Cardama
Bedrijven | Functie | Begin |
---|---|---|
FOGHORN THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 11-09-2023 |
Eerdere bekende functies van Alfonso Quintás-Cardama
Bedrijven | Functie | Einde |
---|---|---|
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Corporate Officer/Principal | 01-01-2014 |
GSK PLC | Corporate Officer/Principal | - |
TCR2 THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Alfonso Quintás-Cardama
University of Santiago de Compostela | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
GSK PLC | Health Technology |
FOGHORN THERAPEUTICS INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Consumer Services |
TCR2 Therapeutics, Inc.
TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |